HCID 86735422, 화합물 → HCID 86735423, 화합물
반응식
[C:1]([OH:4])(=[O:3])[CH3:2].[C:5]([OH:8])(=[O:7])[CH3:6].[OH:9][C@H:10]1[CH2:27][CH2:26][C@@:25]2([CH2:28][OH:29])[C:12](=[CH:13][CH2:14][C@@H:15]3[C@@H:24]2[CH2:23][CH2:22][C@@:20]2([CH3:21])[C@H:16]3[CH2:17][CH2:18][C:19]2=[O:30])[CH2:11]1>CO.[Pd]>[C:1]([OH:4])(=[O:3])[CH3:2].[C:5]([OH:8])(=[O:7])[CH3:6].[OH:9][C@H:10]1[CH2:27][CH2:26][C@@:25]2([CH2:28][OH:29])[C@@H:12]([CH2:13][CH2:14][C@@H:15]3[C@@H:24]2[CH2:23][CH2:22][C@@:20]2([CH3:21])[C@H:16]3[CH2:17][CH2:18][C:19]2=[O:30])[CH2:11]1참가 물질
4
실험 절차
A solution of 3β,19-dihydroxyandrost-5-en-17-one diacetate in methanol is hydrogenated with a 10% Palladium-on-charcoal catalyst at atmospheric pressure for 8 hours. The catalyst is removed by filtration and the filtrate concentrated to a small volume, cooled, and filtered to yield the desired 3β,19-dihydroxy-5α-androstan-17-one diacetate. Recrystallization from hexane results in pure material.